Hypoalbuminemia and hypergammaglobulinemia are associated with an increased infection risk in patients with myeloid malignancies treated with azacitidine. A 3-year monocentric retrospective study - Archive ouverte HAL
Article Dans Une Revue Leukemia & lymphoma Année : 2015

Hypoalbuminemia and hypergammaglobulinemia are associated with an increased infection risk in patients with myeloid malignancies treated with azacitidine. A 3-year monocentric retrospective study

Fichier non déposé

Dates et versions

hal-02331498 , version 1 (24-10-2019)

Identifiants

Citer

Aspasia Stamatoullas, Imène Rezine, Sylvain Mareschal, Anne Lise Ménard, Hélène Lanic, et al.. Hypoalbuminemia and hypergammaglobulinemia are associated with an increased infection risk in patients with myeloid malignancies treated with azacitidine. A 3-year monocentric retrospective study. Leukemia & lymphoma, 2015, 57 (6), pp.1491-1493. ⟨10.3109/10428194.2015.1101096⟩. ⟨hal-02331498⟩
32 Consultations
0 Téléchargements

Altmetric

Partager

More